Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca (KCS) in patients with primary Sjögren's syndrome (SS) not responding to standard treatment with artificial tears;Efficacia di Carbopol 974P (Siccafluid) nel trattamento della cheratocongiuntivite sicca di grado moderato-severo in 60 casi con S. di Sjögren primitiva

Reumatismo

Volumn 57, Issue 2, 2005, Pages 119-124

  Ostuni, Pierantonio ^a,b   Battista, M E C ^c   Furlan, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Cattedra e UOC di Reumatologia   (Italy)

^c NONE

Author keywords

Artificial tears; Carbopol 974P; Keratoconjunctivitis sicca; Sj gren's syndrome

Indexed keywords

ARTIFICIAL TEAR; CARBOPOL 974P; FLUORESCEIN; ROSE BENGAL; SICCAFLUID;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRY EYE; FEMALE; HUMAN; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; OPHTHALMOLOGY; QUESTIONNAIRE; SCHIRMER TEST; SJOEGREN SYNDROME; SYMPTOM; TREATMENT OUTCOME;

ACRYLATES; ADULT; AGED; DRUG RESISTANCE; FEMALE; GELS; HUMANS; KERATOCONJUNCTIVITIS SICCA; LUBRICANTS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SJOGREN'S SYNDROME; STAINING AND LABELING; TEARS;

EID: 27644459592     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fauci AS. Sjogren's syndrome (Sicca syndrome): current issues. Ann Intern Med 1980; 92:212-26.
2. Van Bijsterveld OP. Diagnosis and differential diagnosis of keratoconjunctivitis sicca associated with tear gland degeneration. Clin Exp Rheumatol 1990; 8 Suppl. 5:3-6.
3. Friedlander MH. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca. Rheum Dis Clin North Am 1992; 18:591-608.
4. Foster HE, Gilroy JJ, Kelly CA, Howe J, Griffiths ID. The treatment of sicca features in Sjogren's syndrome: a clinical review. Br J Rheumatol 1994; 33:278-82.
5. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998; 17:584-9.
6. Gambari PF, Ostuni PA, Todesco S. Sindrome di Sjögren: la terapia. XXXII Congresso SIR Atti 92-5, 1995.
7. Fox RI, Tornwall J, Michelson P. Current issues in the diagnosis and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1999; 11:364-71.
8. Gilbard JP. Dry eye: pharmacological approaches, effects, and progress. CLAO J 1996; 22:141-5.
9. Bron AJ, Daubas P, Siou-Mermet R, Trinquand C. Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears. Eye 1998; 12:839-47.
10. Solomon A, Merin S. The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca. J Ocul Pharmacol Ther 1998; 14:497-504.
11. Condon PI, McEwen CG, Wright M, Mackintosh G, Prescott RJ, McDonald C. Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome. Br J Ophthalmol 1999; 83:1121-4.
12. Swanson M. Compliance with and typical usage of artificial tears in dry eye conditions. J Am Optorn Assoc 1998; 69:649-55.
13. Marner K, Mooller PM, Dillon M, Rask-Pedersen E. Viscous carbomer eye drops in patients with dry eyes. Efficacy and safety. A randomized, open, cross-over, multicentre study. Acta Ophthalmol Scand 1996; 74: 249-52.
14. Sullivan LJ, McCurrach F, Lee S, Taylor HR, Rolando M, Marechal-Courtois C. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome. Ophthalmology 1997; 104:1402-8.
15. Pouliquen P. Carbomer gels in the treatment of dry eye J Fr Ophtalmol 1999; 22:903-13.
16. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjogren' s syndrome. Results of a prospective concerted action supported by the European Community .Arthritis Rheum 1993; 36:340-7.
17. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61:554-8.
18. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998; 17:38-56.